123 related articles for article (PubMed ID: 9374921)
21. Long-term chrysotherapy in rheumatoid arthritis.
Srinivasan R; Miller BL; Paulus HE
Arthritis Rheum; 1979 Feb; 22(2):105-10. PubMed ID: 105739
[TBL] [Abstract][Full Text] [Related]
22. Clinical, immunohistochemical, and electron-microscopic findings in gold dermatitis.
Ranki A; Niemi KM; Kanerva L
Am J Dermatopathol; 1989 Feb; 11(1):22-8. PubMed ID: 2521783
[TBL] [Abstract][Full Text] [Related]
23. Rheumatoid arthritis, gold therapy, contact allergy and blood cytokines.
Svensson A; Möller H; Björkner B; Bruze M; Leden I; Theander J; Ohlsson K; Linder C
BMC Dermatol; 2002; 2():2. PubMed ID: 11860615
[TBL] [Abstract][Full Text] [Related]
24. Gold therapy in rheumatoid arthritis.
Schorn D; Anderson IF
S Afr Med J; 1975 Aug; 49(37):1505-6. PubMed ID: 125934
[TBL] [Abstract][Full Text] [Related]
25. [Lichenoid eruption induced by gold salts. An autonomous eruption].
Alzieu PH; Amoric JC; Bureau B; Remond L; Milpied B; Stalder JF; Litoux P
Ann Dermatol Venereol; 1994; 121(11):798-801. PubMed ID: 7631988
[TBL] [Abstract][Full Text] [Related]
26. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
[TBL] [Abstract][Full Text] [Related]
27. [HLA DR7 as a protective factor against gold salt toxicity in rheumatoid arthritis].
Rodríguez Pérez M; González Domínguez J; Matarán Pérez L; Salvatierra Ríos D
An Med Interna; 1993 Oct; 10(10):484-6. PubMed ID: 8136425
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR1-positive patients suffering from rheumatoid arthritis are at high risk for developing mucocutaneous side effects upon gold therapy.
Pickl WF; Fischer GF; Faé I; Kolarz G; Scherak O
Hum Immunol; 1993 Oct; 38(2):127-31. PubMed ID: 7906259
[TBL] [Abstract][Full Text] [Related]
29. Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis.
Dorwart BB; Gall EP; Schumacher HR; Krauser RE
Arthritis Rheum; 1978 Jun; 21(5):513-5. PubMed ID: 96841
[TBL] [Abstract][Full Text] [Related]
30. Adverse reactions to parenteral gold salts.
Tilelli JA; Heinrichs MM
Lancet; 1997 Mar; 349(9055):853. PubMed ID: 9121270
[No Abstract] [Full Text] [Related]
31. Association of IgE antibodies to sodium aurothiomalate and adverse reactions to chrysotherapy for rheumatoid arthritis.
Bretza J; Wells I; Novey HS
Am J Med; 1983 Jun; 74(6):945-50. PubMed ID: 6407306
[TBL] [Abstract][Full Text] [Related]
32. Pityriasis rosea and discoid eczema: dose related reactions to treatment with gold.
Wilkinson SM; Smith AG; Davis MJ; Mattey D; Dawes PT
Ann Rheum Dis; 1992 Jul; 51(7):881-4. PubMed ID: 1385941
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow gold.
Bareford D; Wyre J; Pace AV
Br J Haematol; 2012 Jan; 156(2):153. PubMed ID: 22054914
[No Abstract] [Full Text] [Related]
34. [The Tauredon treatment of rheumatoid arthritis patients: its efficacy and tolerance when used long term].
Murav'ev IuV; Nasonova VA; Ivanova MM; Taukumova LA
Ter Arkh; 1996; 68(5):16-8. PubMed ID: 9082589
[No Abstract] [Full Text] [Related]
35. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA.
Singal DP; Green D; Reid B; Gladman DD; Buchanan WW
Ann Rheum Dis; 1992 Jan; 51(1):23-8. PubMed ID: 1371662
[TBL] [Abstract][Full Text] [Related]
36. [Cutaneous reactions to gold salts].
Bonnetblanc JM
Presse Med; 1996 Oct; 25(32):1555-8. PubMed ID: 8952665
[TBL] [Abstract][Full Text] [Related]
37. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
[TBL] [Abstract][Full Text] [Related]
38. Gold sodium thiomalate (GTM) induces hypersensitivity to thiomalate, the thiol carrier of GTM.
Ikezawa Z; Kitamura K; Nakajima H
J Dermatol; 1990 Sep; 17(9):550-4. PubMed ID: 2148942
[TBL] [Abstract][Full Text] [Related]
39. Liver toxicity profile in gold-treated Egyptian rheumatoid arthritis patients.
Koryem HK; Taha KM; Ibrahim IK; Younes LK
Int J Clin Pharmacol Res; 1998; 18(1):31-7. PubMed ID: 9604732
[TBL] [Abstract][Full Text] [Related]
40. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
Ernestam S; Lampa J; Rogberg S; Rönnelid J; Klareskog L; Hafström I
J Rheumatol; 2003 Aug; 30(8):1748-55. PubMed ID: 12913930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
